POLYPHENOLS FROM RED WINE MODULATE IMMUNE RESPONSIVENESS: BIOLOGICAL AND CLINICALSIGNIFICANCE.

Giuseppina Candore, Calogero Caruso, Magrone, Covelli, Emilio Jirillo

Risultato della ricerca: Article

42 Citazioni (Scopus)

Abstract

Many studies have been conducted on the effects of red wine polyphenols on certain diseases, primarily, coronaryheart disease (CHD) and, in this respect, evidence has been demonstrated that intake of red wine is associated with areduction of CHD symptomatology. In this framework, the purpose of this review is to illustrate the effects of polyphenolson immune cells from human healthy peripheral blood. Data will show that polyphenols are able to stimulate both innateand adaptive immune responses. In particular, the release of cytokines such as interleukin (IL)-12, interferon (IFN)-, andIL-10 as well as immunoglobulins may be important for host protection in different immune related disorders.Another important aspect pointed out in this review is the release of nitric oxide (NO) from peripheral blood mononuclearcells (PBMC), stimulated by red wine polyphenols despite the fact that the majority of studies have reported NO productiononly by endothelial cells. Release of NO from PBMC may play an important role in cardiovascular disease, because itis known that this molecule acts as an inhibitor of platelet aggregation. On the other hand, NO exerts a protective roleagainst infectious organisms.Finally, some molecular cytoplasmatic pathways elicited by polyphenols able to regulate certain immune responses willalso be discussed. In particular, it seems that p38, a molecule belonging to the MAPK family, is involved in the release ofIFN- and, therefore, in NO production.All these data confirm the beneficial effects of polyphenols in some chronic diseases.
Lingua originaleEnglish
pagine (da-a)2733-2748
Numero di pagine16
RivistaCURRENT PHARMACEUTICAL DESIGN
Volume14
Stato di pubblicazionePublished - 2008

Fingerprint

Polyphenols
Wine
Nitric Oxide
Platelet Aggregation Inhibitors
Immune System Diseases
Adaptive Immunity
Interleukin-12
Interferons
Immunoglobulins
Chronic Disease
Cardiovascular Diseases
Endothelial Cells
Cytokines

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cita questo

POLYPHENOLS FROM RED WINE MODULATE IMMUNE RESPONSIVENESS: BIOLOGICAL AND CLINICALSIGNIFICANCE. / Candore, Giuseppina; Caruso, Calogero; Magrone; Covelli; Jirillo, Emilio.

In: CURRENT PHARMACEUTICAL DESIGN, Vol. 14, 2008, pag. 2733-2748.

Risultato della ricerca: Article

@article{638b56179808443187b448ab715c9eca,
title = "POLYPHENOLS FROM RED WINE MODULATE IMMUNE RESPONSIVENESS: BIOLOGICAL AND CLINICALSIGNIFICANCE.",
abstract = "Many studies have been conducted on the effects of red wine polyphenols on certain diseases, primarily, coronaryheart disease (CHD) and, in this respect, evidence has been demonstrated that intake of red wine is associated with areduction of CHD symptomatology. In this framework, the purpose of this review is to illustrate the effects of polyphenolson immune cells from human healthy peripheral blood. Data will show that polyphenols are able to stimulate both innateand adaptive immune responses. In particular, the release of cytokines such as interleukin (IL)-12, interferon (IFN)-, andIL-10 as well as immunoglobulins may be important for host protection in different immune related disorders.Another important aspect pointed out in this review is the release of nitric oxide (NO) from peripheral blood mononuclearcells (PBMC), stimulated by red wine polyphenols despite the fact that the majority of studies have reported NO productiononly by endothelial cells. Release of NO from PBMC may play an important role in cardiovascular disease, because itis known that this molecule acts as an inhibitor of platelet aggregation. On the other hand, NO exerts a protective roleagainst infectious organisms.Finally, some molecular cytoplasmatic pathways elicited by polyphenols able to regulate certain immune responses willalso be discussed. In particular, it seems that p38, a molecule belonging to the MAPK family, is involved in the release ofIFN- and, therefore, in NO production.All these data confirm the beneficial effects of polyphenols in some chronic diseases.",
keywords = "ATHEROSCLEROSIS, CYTOKINES, IMMUNE SYSTEM, IMMUNOGLOBULINS, NITRIC OXIDE, POLYPHENOLS, RED WINE",
author = "Giuseppina Candore and Calogero Caruso and Magrone and Covelli and Emilio Jirillo",
year = "2008",
language = "English",
volume = "14",
pages = "2733--2748",
journal = "CURRENT PHARMACEUTICAL DESIGN",
issn = "1381-6128",

}

TY - JOUR

T1 - POLYPHENOLS FROM RED WINE MODULATE IMMUNE RESPONSIVENESS: BIOLOGICAL AND CLINICALSIGNIFICANCE.

AU - Candore, Giuseppina

AU - Caruso, Calogero

AU - Magrone, null

AU - Covelli, null

AU - Jirillo, Emilio

PY - 2008

Y1 - 2008

N2 - Many studies have been conducted on the effects of red wine polyphenols on certain diseases, primarily, coronaryheart disease (CHD) and, in this respect, evidence has been demonstrated that intake of red wine is associated with areduction of CHD symptomatology. In this framework, the purpose of this review is to illustrate the effects of polyphenolson immune cells from human healthy peripheral blood. Data will show that polyphenols are able to stimulate both innateand adaptive immune responses. In particular, the release of cytokines such as interleukin (IL)-12, interferon (IFN)-, andIL-10 as well as immunoglobulins may be important for host protection in different immune related disorders.Another important aspect pointed out in this review is the release of nitric oxide (NO) from peripheral blood mononuclearcells (PBMC), stimulated by red wine polyphenols despite the fact that the majority of studies have reported NO productiononly by endothelial cells. Release of NO from PBMC may play an important role in cardiovascular disease, because itis known that this molecule acts as an inhibitor of platelet aggregation. On the other hand, NO exerts a protective roleagainst infectious organisms.Finally, some molecular cytoplasmatic pathways elicited by polyphenols able to regulate certain immune responses willalso be discussed. In particular, it seems that p38, a molecule belonging to the MAPK family, is involved in the release ofIFN- and, therefore, in NO production.All these data confirm the beneficial effects of polyphenols in some chronic diseases.

AB - Many studies have been conducted on the effects of red wine polyphenols on certain diseases, primarily, coronaryheart disease (CHD) and, in this respect, evidence has been demonstrated that intake of red wine is associated with areduction of CHD symptomatology. In this framework, the purpose of this review is to illustrate the effects of polyphenolson immune cells from human healthy peripheral blood. Data will show that polyphenols are able to stimulate both innateand adaptive immune responses. In particular, the release of cytokines such as interleukin (IL)-12, interferon (IFN)-, andIL-10 as well as immunoglobulins may be important for host protection in different immune related disorders.Another important aspect pointed out in this review is the release of nitric oxide (NO) from peripheral blood mononuclearcells (PBMC), stimulated by red wine polyphenols despite the fact that the majority of studies have reported NO productiononly by endothelial cells. Release of NO from PBMC may play an important role in cardiovascular disease, because itis known that this molecule acts as an inhibitor of platelet aggregation. On the other hand, NO exerts a protective roleagainst infectious organisms.Finally, some molecular cytoplasmatic pathways elicited by polyphenols able to regulate certain immune responses willalso be discussed. In particular, it seems that p38, a molecule belonging to the MAPK family, is involved in the release ofIFN- and, therefore, in NO production.All these data confirm the beneficial effects of polyphenols in some chronic diseases.

KW - ATHEROSCLEROSIS

KW - CYTOKINES

KW - IMMUNE SYSTEM

KW - IMMUNOGLOBULINS

KW - NITRIC OXIDE

KW - POLYPHENOLS

KW - RED WINE

UR - http://hdl.handle.net/10447/59411

M3 - Article

VL - 14

SP - 2733

EP - 2748

JO - CURRENT PHARMACEUTICAL DESIGN

JF - CURRENT PHARMACEUTICAL DESIGN

SN - 1381-6128

ER -